The portfolio, in detail.
What each console actually does — its capabilities and the classifications and guidelines it implements — across three divisions, from acute stroke to whole-person neurology.
Neurology Bedside Consoles
6 toolsCerebro
See it in operation → a short demonstration of the console
What it does. The flagship acute console for the hyperacute stroke pathway and rapid bedside neurology. It runs a last-known-well clock, scores stroke severity, computes weight-based thrombolysis dosing and drives lesion localisation directly from the examination — one workspace from door to decision, with a copy-ready note.
Key capabilities
- Last-known-well timer with thrombolysis-window tracking
- NIHSS calculator with itemised scoring
- Weight-based thrombolysis (alteplase / tenecteplase) dose calculator
- Vascular-risk and bleeding scores: ABCD², CHA₂DS₂-VASc, HAS-BLED
- Subarachnoid grading: Hunt & Hess and Fisher
- Lesion localiser — select examination findings to generate a localisation
- Imaging prompts and a structured plan builder
- Patient profiles/sessions, copy-to-clipboard note; role- and specialty-aware (neurology, emergency medicine, neurosurgery)
Acute decision support — verify dosing and thrombolysis/thrombectomy eligibility against local protocol.
Ictal Pilot
What it does. A whole-person epilepsy console that moves from witnessed semiology to syndrome to treatment. A classifier builds the full ILAE 2017 operational descriptor, a semiology localiser infers the epileptogenic network from aura and ictal features, and an antiseizure-medication selector with a dedicated women-with-epilepsy module handles treatment — all within a structured patient workspace that auto-generates the note.
Key capabilities
- Seizure/epilepsy classifier: category → candidate syndromes → aetiology in parallel (ILAE 2017/2022)
- Semiology localiser from aura/first symptom and ictal motor/behavioural features, with a lateralising-signs reference
- Seizure clock and structured history
- Antiseizure-medication selector
- Women & epilepsy: teratogenic risk by ASM (EURAP / MONEAD), preconception, contraception interactions, pregnancy, catamenial epilepsy, breastfeeding
- Autoimmune epilepsy: when to suspect, antibody–syndrome pairings, management
- Patient workspace with saved patients and an on-device performance audit; auto-generated clinical note & differential
NeuroMotion
What it does. A phenomenology-first movement-disorders workspace. It localises the phenomenology, supplies discriminators, applies formal diagnostic criteria, computes the levodopa-equivalent daily dose and assesses device/DBS candidacy — ending in an auto-generated note.
Key capabilities
- Phenomenology localiser and discriminator quick-reference
- MDS 2015 clinical diagnostic criteria for Parkinson’s disease
- Leipzig score for Wilson’s disease
- Structured examination, assessment and investigations
- Levodopa-equivalent daily dose (LEDD) calculator
- Medications-tried log and surgical / device (DBS) candidacy
- Patient list and auto-generated note
NM Console
What it does. From bedside sign to localised diagnosis across the motor unit. A compartment localiser weights muscle, nerve, neuromuscular junction and anterior horn and drives a ranked differential — with a myopathy/myositis localiser (antibody links and a dermatomyositis skin atlas), a neuropathy classifier, Gold Coast ALS criteria and a crisis pad that separates myasthenic from cholinergic crisis.
Key capabilities
- Compartment localiser: muscle / nerve / NMJ / motor neuron
- Myopathy & myositis localiser with myositis-antibody associations and a dermatomyositis skin atlas
- Neuropathy classifier; NMJ workups (myasthenia gravis, LEMS) with a LEMS→malignancy pathway
- Gold Coast (2020) ALS diagnostic-criteria checklist
- Statin-myopathy scenarios and GBS bedside essentials
- Crisis pad: myasthenic vs cholinergic crisis
- Calculators and Vancouver-referenced sources
Neuro-Onco Console
What it does. A neuro-oncology console that reasons from the scan to the molecular diagnosis to the plan. An imaging-signature engine and compartment-based differential feed a tumour compendium built on the WHO 2021 CNS molecular layer, with classic radiologic signs, surgical planning and treatment protocols in a holistic frame.
Key capabilities
- Imaging Signature Engine and compartment-based differential
- Classic radiologic-signs reference
- Tumour compendium
- WHO 2021 CNS integrated histomolecular classification layer
- Surgical planning and treatment protocols
- Holistic / whole-person and references sections
HOLOS
What it does. The longitudinal, biopsychosocial counterpart to the acute consoles. A 360° HoloMap assessment spans whole-person scales, supportive and palliative care, neurorehabilitation and neuroplasticity, brain-health prevention and goals of care — with a paediatric Neuropedia layer.
Key capabilities
- HoloMap — 360° whole-person assessment
- Whole-person scales
- Supportive & palliative care
- NeuroRehab & neuroplasticity
- Brain health & prevention
- Goals of care; Neuropedia (paediatric)
Clinical Platforms
4 toolsNEURAXIS
What it does. The command layer that unifies the subspecialty consoles. Each tool runs as an isolated, state-preserved module behind a single command palette — an operating system for bedside neurology.
Key capabilities
- Module launcher hosting the subspecialty consoles as isolated modules
- State-preserved modules (work in one console is retained when you switch)
- Command-palette navigation across the suite
VITALIS
What it does. A full hospital-information-system substrate demonstrating how the clinical consoles plug into a live record. It models inpatients, observations, results, problems, medications and orders, layered with NEWS2, embedded calculators, FHIR R4 interoperability and an AI co-pilot. A technology prototype on synthetic data only.
Key capabilities
- Active inpatient list, latest observations, recent results
- Problem list, medications, medication orders and the medication administration record
- Investigations & tasks; critical-result acknowledgement
- NEWS2 breakdown and trend
- Embedded calculators: NIHSS, thrombolysis dosing, CHA₂DS₂-VASc
- Allergy profile and drug-interaction checker; immutable audit event log
- AI Co-Pilot next actions; predictive deterioration (next 6–8 h); intelligent dose advisory; autonomous stroke pathway
- Terminology & interoperability (live FHIR R4); system-architecture module map; ⌘K search
Technology prototype / demonstrator on synthetic data — not for clinical use.
HumAx
What it does. The clinician-facing shell built on the VITALIS substrate — a sign-in-gated, end-to-end clinical system that unites the specialty consoles and validated calculators into one workspace. Prototype, synthetic data only.
Key capabilities
- Authenticated clinician workspace over the VITALIS substrate
- Unified inpatient list, observations, results, problems and medications
- Embedded calculators and specialty decision support
- AI co-pilot, predictive deterioration, dose advisory and stroke pathway
- System-architecture map and FHIR R4 interoperability
Technology prototype / demonstrator on synthetic data — not for clinical use.
PULSE
What it does. Operational analytics that turn clinical activity into performance and quality signals across departments, consultants and residents — with diagnosis tracking and flexible reporting windows.
Key capabilities
- Department, consultant and resident performance views
- Admission impression → working diagnosis → final diagnosis tracking (diagnostic concordance)
- Reporting windows: today, yesterday, 7 / 30 days, quarter, 12 months, fiscal YTD, custom
Training & Simulation
2 toolsNEURAXIS Bedside Simulator
What it does. A seven-phase clinical-reasoning simulator. From a referral you clerk, examine, investigate, localise, lock the localisation and commit a diagnosis before a structured debrief — with a cognitive-bias and safety coach throughout.
Key capabilities
- Case bank with referral selection and a clerking log
- Seven-phase flow: history → examination → investigations → localise → lock localisation → commit diagnosis → debrief
- Cognitive-bias & safety coach with safety checks
- Structured debrief: localisation walk-through, differential & discriminators, confirmatory pathway, management & red flags, teaching pearls, holistic view, Vancouver references
- Replay and next-case progression
NeuroDeck
What it does. A spaced-repetition MCQ trainer across the subspecialties. Build blocks by topic, repeat your misses via a recall stack, flag items and track mastery by subspecialty — with a full authoring console and backup.
Key capabilities
- Subspecialty-mastery dashboard and per-block statistics
- Session builder: pick or mix topics; modes — mixed, in order, unseen only, flagged only
- Recall stack (repeat your misses) and flagged items
- Authoring: write one or bulk-JSON import; export/import bank and backup
Sources
Key standards implemented across the consoles. Content is decision support and must be verified against current primary sources and local protocols.
- Powers WJ, Rabinstein AA, Ackerson T, et al. Guidelines for the early management of patients with acute ischaemic stroke: 2019 update. Stroke. 2019;50(12):e344–e418.
- Brott T, Adams HP, Olinger CP, et al. Measurements of acute cerebral infarction: a clinical examination scale (NIHSS). Stroke. 1989;20(7):864–870.
- Fisher RS, Cross JH, French JA, et al. Operational classification of seizure types by the ILAE. Epilepsia. 2017;58(4):522–530.
- Wirrell EC, Nabbout R, Scheffer IE, et al. Methodology for classification and definition of epilepsy syndromes: ILAE 2022. Epilepsia. 2022;63(6):1333–1348.
- Tomson T, Battino D, Bonizzoni E, et al. Comparative risk of major congenital malformations with antiepileptic drugs: EURAP registry. Lancet Neurol. 2018;17(6):530–538.
- Postuma RB, Berg D, Stern M, et al. MDS clinical diagnostic criteria for Parkinson’s disease. Mov Disord. 2015;30(12):1591–1601.
- Shefner JM, Al-Chalabi A, Baker MR, et al. A proposal for new diagnostic criteria for ALS (Gold Coast). Clin Neurophysiol. 2020;131(8):1975–1978.
- Louis DN, Perry A, Wesseling P, et al. The 2021 WHO Classification of Tumors of the Central Nervous System: a summary. Neuro Oncol. 2021;23(8):1231–1251.
- Royal College of Physicians. National Early Warning Score (NEWS) 2. London: RCP; 2017.
- HL7 International. Fast Healthcare Interoperability Resources (FHIR) Release 4. 2019.